| IELSG57 | Characterization of primary central nervous system diffuse large B cell lymphoma (PCNS-DLBCL) by multiomic approach |
| Samples required | at least 100 patients |
| Investigator responsible(s) | M. Paulli, M. Lucioni |
| Objective(s) | Comprehensive analysis of PCNS-DLBCL cohort to identify biologically and clinically validated subgroups or prognosis and therapy. |
| Lay summary | Primary central nervous system lymphoma (PCNSL) is a rare and aggressive type of lymphoma that mainly affects the brain, spinal cord, or eyes. The most common form is called diffuse large B-cell lymphoma (DLBCL). Standard treatment usually includes high doses of chemotherapy, sometimes followed by a stem cell transplant or radiotherapy. However, many patients either do not respond to treatment or relapse after an initial response, and the treatments themselves can cause serious side effects. Recent research has revealed specific genetic changes in PCNSL that may explain why it grows so aggressively and resists the immune system. Understanding these changes and the role of the tumor environment in the brain may help scientists develop more effective and less toxic therapies in the future. |
| DPIA | Impact Assessment on Data Processing |